Skip to content

Drug interactions

Dihydroergotamine + Paliperidone

Severity: Moderate

Dihydroergotamine and Paliperidone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs act on serotonergic and dopaminergic pathways, so the combination could theoretically raise the risk of serotonin toxicity or neuroleptic malignant syndrome. Clinical evidence for a meaningful interaction is sparse. Dihydroergotamine also causes vasoconstriction, and the relevance of this to paliperidone is unclear.

What this interaction means in plain words

Dihydroergotamine and Paliperidone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dihydroergotamine belongs to Central Nervous System; Paliperidone belongs to Central Nervous System.

Evidence level: Low

Why it happens

Theoretical overlapping serotonergic and dopaminergic receptor effects; no firmly established mechanism.

What to do

Monitor for altered mental status, autonomic instability, neuromuscular hyperactivity, fever or rigidity. Stop one or both drugs if features of serotonin toxicity or neuroleptic malignant syndrome develop.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dihydroergotamine and Paliperidone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dihydroergotamine with Paliperidone?

MediHelp rates the interaction as moderate. Dihydroergotamine and Paliperidone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs act on serotonergic and dopaminergic pathways, so the combination could theoretically raise the risk of serotonin toxicity or neuroleptic malignant syndrome. Clinical evidence for a meaningful interaction is sparse. Dihydroergotamine also causes vasoconstriction, and the relevance of this to paliperidone is unclear.

How serious is the interaction between Dihydroergotamine and Paliperidone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for altered mental status, autonomic instability, neuromuscular hyperactivity, fever or rigidity. Stop one or both drugs if features of serotonin toxicity or neuroleptic malignant syndrome develop.

What other medicines interact with Paliperidone?

MediHelp also lists interactions of Paliperidone with, for example, Ibutilide, Pimozide, Vandetanib. The full list is on the Paliperidone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in